Journal of the American Academy of Dermatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from sprout, a randomized controlled trial
Approved systemic treatment options are limited for pediatric patients with moderate to severe plaque psoriasis. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 22, 2024 Category: Dermatology Authors: Loretta Fiorillo, Emily Becker, Raul de Lucas, Anna Belloni-Fortina, Susana Armesto, Boni Elewski, Peter Maes, Rajneet K. Oberoi, Maria Paris, Wendy Zhang, Zuoshun Zhang, Lisa Arkin Source Type: research

Adverse events after empiric antibiotic administration in dermatologic surgery: A global, propensity-matched, retrospective cohort study
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 22, 2024 Category: Dermatology Authors: Kyle C. Lauck, Seo Won Cho, Jace Rickstrew, Stanislav N. Tolkachjov Source Type: research

An Assessment of Skin Cancer Incidence in Patients with Hidradenitis Suppurativa
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 22, 2024 Category: Dermatology Authors: Lauren Sattele, Laura Andrews, Chelsea Shope, Lara Wine Lee, Colleen H. Cotton Source Type: research

A randomized, controlled pilot study of oral roflumilast compared to intramuscular methotrexate for plaque and scalp psoriasis
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 22, 2024 Category: Dermatology Authors: Dina G. Saadi, Mohamed HM. EL-Komy, Hadeer Khedr, Nevine Shawky, Amira Aly Hegazy, Yousra Azzazi, Aya M. AlOrbani Source Type: research

Excision margins for melanoma in situ on the head and neck —A single-center 10-year retrospective review of treatment with Mohs micrographic surgery
Although current guidelines recommend a 5  mm surgical margin for the excision of melanoma in situ (MIS), increasing evidence has shown this may be suboptimal to achieve tumor clearance. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 20, 2024 Category: Dermatology Authors: Jesalyn A. Tate, Andrew Matsumoto, Charlotte Greif, Jorena Lim, Rajiv I. Nijhawan, Divya Srivastava Tags: Original article Source Type: research

Decoding real-world outcomes: exploring clinical features associated with efficacy in patients treated with dupilumab
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 20, 2024 Category: Dermatology Authors: Zequn Tong, Kunli Zhou, Ying Zou, Zhenlan Wu, Jiawen Chen, Chenyao Xue, Zheyu Zhuang, Yifan Zhao, Liangqi Cai, Ting Gong, Chao Ji Source Type: research

Excision Margins for Melanoma in Situ on the Head and Neck – A Single-Center 10-year Retrospective Review of Treatment with Mohs Micrographic Surgery
While current guidelines recommend a 5mm surgical margin for the excision of melanoma in situ (MIS), increasing evidence has shown this may be suboptimal to achieve tumor clearance. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 20, 2024 Category: Dermatology Authors: Jesalyn A. Tate, Andrew Matsumoto, Charlotte Greif, Jorena Lim, Rajiv I. Nijhawan, Divya Srivastava Source Type: research

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial
The topical phosphodiesterase 4 inhibitor roflumilast has been studied in several dermatologic conditions. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 20, 2024 Category: Dermatology Authors: Andrew Blauvelt, Zoe D. Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Janet DuBois, Seth B. Forman, Melinda Gooderham, Lawrence Green, Scott T. Guenthner, Adelaide A. Hebert, Edward Lain, Angela Y. Moore, Kim A. Papp, Matthew Zirwas, S Source Type: research

Baricitinib for the treatment of alopecia areata in adults: Real-world analysis of 36 patients
This study aims to assess baricitinib ’s real-world efficacy and safety in AA. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 19, 2024 Category: Dermatology Authors: Carlos Moreno-V ílchez, Montserrat Bonfill-Ortí, Andrea Bauer-Alonso, Jaime Notario, Ignasi Figueras-Nart Tags: Research letter Source Type: research

Asynchronous direct to patient teledermatology visits (e-visits) during COVID-19 pandemic: Lessons for future teledermatology practice
To the Editor: Teledermatology  became an essential mode of health care during the COVID-19 pandemic; this was facilitated by the Centers for Medicare and Medicaid Services 1135 waiver, providing parity compensation for telehealth services (synchronous visits) and allowing services to be rendered from patients’ homes via non-H ealth Insurance Portability and Accountability Act compliant platforms.1 We aimed to provide insights into diagnoses best suitable for direct to patient asynchronous teledermatology (e-visit), and sought to understand how demographics may contribute to the utilization of telehealth visits. (Sourc...
Source: Journal of the American Academy of Dermatology - January 19, 2024 Category: Dermatology Authors: Nicole Trupiano, Rebecca H. Goldberg, Madison Novice, Jianheng Mai, Haihan Zhang, Sruthi Renati, Mari Paz Castanedo-Tardan, Trilokraj Tejasvi Tags: Research letter Source Type: research

This Month in JAAD Case Reports: April 2024: Anifrolumab for subacute cutaneous lupus
Anifrolumab is a first-in-class type I interferon receptor antibody approved by the United States Food and Drug Administration in 2021 for moderate to severe systemic lupus erythematosus. Each of the 3 major anifrolumab clinical trials carried a secondary end point evaluating cutaneous lupus erythematosus (CLE) improvement, though the subtypes of CLE were not reported. At week 52, 46% to 65% of patients on anifrolumab versus 25% to 31% on placebo with a Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity (CLASI-A) of ≥10 at baseline achieved a ≥50% reduction in CLASI-A. (Source: Journal of the Americ...
Source: Journal of the American Academy of Dermatology - January 19, 2024 Category: Dermatology Authors: Brett Sloan Tags: This month in Source Type: research

This Month in JAAD Case Reports: April 2024 Anifrolumab for subacute cutaneous lupus
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 19, 2024 Category: Dermatology Authors: Brett Sloan Source Type: research

Baricitinib for the Treatment of Alopecia Areata in Adults: Real-World Analysis of 36 Patients.
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 19, 2024 Category: Dermatology Authors: C. Moreno-V ílchez, M. Bonfill-Ortí, A. Bauer-Alonso, J. Notario., I. Figueras-Nart Source Type: research

Asynchronous Direct-to-Patient Teledermatology Visits (E-visits) during COVID-19 Pandemic: Lessons for future teledermatology practice.
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 19, 2024 Category: Dermatology Authors: Nicole Trupiano, Rebecca H. Goldberg, Madison Novice, Jianheng Mai, Haihan Zhang, Sruthi Renati, Mari Paz Castanedo-Tardan, Trilokraj Tejasvi Source Type: research

Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic Accuracy Study
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 18, 2024 Category: Dermatology Authors: Naweed Shifai, Remco van Doorn, Josep Malvehy, Tobias Sangers Source Type: research